the efficacy of direct acting antiviral therapy in patients with chronic hepatitis c

• DOI: 10.5281/zenodo.3700945
• Publication Date: 2020-03-31
• Authors: Medical Parasitology; Liliana Hodorogea; Tiberiu Holban; Irina Rusu
• Keywords: 0301 basic medicine; ledipas-vir; ledipasvir; HVC cronică; Tratament; treatment; Science; Q; R; sofosbuvir; chronic hcv; chronic HCV; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Medicine; daclatasvir

Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV is up to 80% of patients, of whom 10-20% can develop liver cir-rhosis or hepatocellular carcinoma which can lead to death. Treatment with direct-acting antiviral agents (DAAs) contributes to a sustained virological response (SVR) in 97-99% of cases.